Nuclear Imaging of Neuroendocrine Tumors

Nuclear Image Analysis Study of Neuroendocrine Tumors

BACKGROUND There is a subjective disagreement about nuclear chromatin in the field of pathology. Objective values of red, green, and blue (RGB) light intensities for nuclear chromatin can be obtained through a quantitative analysis using digital images. METHODS We examined 10 cases of well differentiated neuroendocrine tumors of the rectum, small cell lung carcinomas, and moderately different...

Neuroendocrine Tumors (NET) and Nuclear Medicine

The term NET groups together different types of cancer that develop in various regions of the human body. They are born, in fact, by cells with characteristics partly similar to nerve cells ("neuro") partly similar to the endocrine ones, scattered almost everywhere in the human organism. So, some NET develop in endocrine glands (such as adrenals, pituitary gland and pancreas), while others affe...

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

The landscape of treatment options in neuroendocrine tumors (NET) has changed in the last 5 years. Novel targeted drugs have been introduced and approved for distinct types of NET. Furthermore, with the first randomized trial on 177 LuDOTATATE peptide receptor radionuclide therapy (PRRT) in midgut NET, not only is approval of this treatment awaited but also its more widespread use. Techniques a...

Developmental trends in targeted radionuclide therapy of neuroendocrine tumors

  Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms including carcinoids, pancreatic neuroendocrine tumors, pituitary tumors, medullary thyroid carcinoma and phaeochromocytomas. The symptoms and the outcome of NETs differ considerably between patients depending on several factors. By labelling tracers with a radioisotope, the tracer acts as a ...

Nuclear roundness in neuroendocrine tumors of the lung